Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Yue Shi, Mei Dong, Xiaoting Hong, +15

Annals of Oncology

Lymphoid NeoplasiaMedicineImmunologyPathologyAutoimmunity +5

Pyrotinib in <i>HER2</i>-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

Caicun Zhou, Xingya Li, Qiming Wang, +14

Journal of Clinical Oncology

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Yunpeng Yang, Jianya Zhou, Jianying Zhou, +37

The Lancet Respiratory Medicine

Biomarker AnalysisMedicinePharmacologyPathologyBronchial Neoplasm +6

Efficient CRISPR-Cas9 Gene Disruption System in Edible-Medicinal Mushroom Cordyceps militaris

Bai‐Xiong Chen, Tao Wei, Zhiwei Ye, +5

Frontiers in Microbiology

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

Ying Cheng, Yun Fan, Yanqiu Zhao, +15

Journal of Thoracic Oncology

Phase 3Clinical TherapeuticPharmacologyClinical TrialsFirst-line Treatment +5

Structural characterization and immune-enhancing activity of a novel high-molecular-weight polysaccharide from Cordyceps militaris

Baolin He, Qianwang Zheng, Li‐Qiong Guo, +4

International Journal of Biological Macromolecules

Natural PolymerGlycobiologyPolysaccharideCarbohydrate-protein InteractionMicrobiology +7

Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial

Tao Jiang, Pingyang Wang, Jie Zhang, +21

Signal Transduction and Targeted Therapy

Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer

Yun Fan, Binghe Xu, Peng Yuan, +6

Annals of Oncology

Breast OncologyOncologyMedicineBreast CancerFirst-line Treatment +5

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Jie Zhang, Yueyin Pan, Qin Shi, +37

Cancer Communications

Immune microenvironment features and efficacy of <scp>PD‐1/PD‐L1</scp> blockade in non‐small cell lung cancer patients with <scp><i>EGFR</i></scp> or <scp><i>HER2</i></scp> exon 20 insertions

Kaiyan Chen, Guoqiang Pan, Guoping Cheng, +4

Thoracic Cancer